Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Bayer/Cellectis extend gene editing pact

Bayer CropScience and French genomics company Cellectis' US subsidiary, Cellectis Plant Sciences (New Brighton, Minnesota), have agreed two new deals covering gene editing in plants. The partnership seeks to create commercial traits for the canola seed market using new technologies developed by Cellectis, and provide Bayer with access to technologies that enable the directed engineering of plant genomes, such as gene stacking and targeted mutagenesis, for the development of improved crops. The agreements extend the companies' existing partnership to introduce targeted modifications to selected plant genes and genomes. The companies signed a deal giving Bayer access to Cellectis' meganuclease technology in 2012 (Agrow No 632, p 20). That extended a collaboration that began in 2006 (Agrow No 499, p 5).


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts